Neil A. Iscoe
Sunnybrook Health Science Centre · 33 works · 730 citations · h-index 13
Top works
- Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
- Variation in breast cancer surgery in Ontario.
- Results of a survey of Canadian men with prostate cancer.
- A Phase II Study of Methotrexate, Vinblastine, Doxorubicin and Cisplatin Plus Recombinant Human Granulocyte-Macrophage Colony Stimulating Factors in Patients with Advanced Transitional Cell Carcinoma
- A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
- Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference?
- The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma
- Re-evaluating the cost of outpatient cancer chemotherapy.
- Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma
- Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
- Predictive Value of Staging Investigations in Patients with Clinical Stage I Malignant Melanoma
- Prostate cancer: 1. The descriptive epidemiology in Canada.
- Treatment of primary hepatocellular carcinoma by hepatic arterial infusion of 4'-epirubicin
- Predicting psychological distress in patients with cancer: conceptual basis and reliability evaluation of a self-report questionnaire.
- Prostate cancer patients' satisfaction with medical information.
- A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer.
- Avelumab in unresectable/metastatic, progressive, grade 2–3 neuroendocrine neoplasms (NENs): Combined results from NET-001 and NET-002 trials
- Pemetrexed in advanced non-small cell lung cancer: A randomized trial of 500 mg/m2 vs 900 mg/m2 in 588 patients who progressed after platinum-containing chemotherapy
- Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.
- Free-standing health care facilities: financial arrangements, quality assurance and a pilot study.